Precipio
Healthcare Services · Connecticut, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4 Science Park, New Haven, Connecticut, ...Phone Number
(203) 787-7888Website
www.precipiodx.comRevenue
$25.8 MillionStock Symbol
PRPOIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
5
3
5
4
4
3
About Precipio
Precipio, Inc., founded in 2011 and based in New Haven, Connecticut, is a specialized diagnostics company focused on reducing cancer misdiagnosis. The company partners with leading academic institutions in cancer research, diagnostics, and treatment to provide high-quality pathology services and diagnostic insights. Through its platform, Precipio delivers accurate, expert-driven diagnostic information to physicians and their patients, aiming to improve clinical decision-making and patient outcomes.Explore more
Precipio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precipio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Precipio launches new products
Funding: Get notified immidiatlly once Precipio has new funding data
Check out if Precipio is spiking on competitors!
Check if Precipio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Precipio
Click to see if Precipio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Precipio recently announced quarterly report
Precipio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Precipio
Find 3 more new buyers
Compare Similar Companies to Precipio
Compare insights from companies similar to Precipio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Precipio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Precipio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Precipio.
Precipio financials insights
Gather financial insights about Precipio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Precipio Tech Stack
A closer look at the technologies used by Precipio
Most Recent Scoops
Project
Precipio has announced the launch of a BCR-ABL assay for monitoring patients with chronic leukemia, which the company describes as among the most advanced available in the market, developed in approximately three months at a cost of under $100,000. Precipio recently published a study in collaboration with Memorial Sloan Kettering highlighting the assay's advantages.
Medical Research, Pharmaceuticals
Partnership
Precipio has partnered with four major distributors, including McKesson and Thermo Fisher, to expand market access for its diagnostic assays by leveraging the distributors' established relationships with laboratory customers. The partnerships provide Precipio access to distributor sales networks in exchange for a 20% margin.
Partnership, Sales
Project
Precipio has announced the launch of a rapid AML (Acute Myeloid Leukemia) test, a four-hour diagnostic panel designed to identify acute leukemia and guide targeted therapy selection on the same day a sample is received. Precipio states it is the only company in the world currently offering this test with a four-hour turnaround.
Earnings
Precipio has reported an anticipated revenue run rate of approximately $25 million at the end of fiscal 2025, with approximately 90% derived from its legacy laboratory services division and approximately 10% from its products division. The company projects the revenue mix will shift to approximately 60% services and 40% products over the next three to five years, with product margins expected to reach approximately 80% at scale.
Earnings, Forecasting, Finance
Person-Based
Events, Public Relations
Precipio News & Media
Precipio Announces Q2-2026 Shareholder Update Call
Conference Call will be held on August 17th, 2026, at 5:00 PM EDT Conference Call will be held on August 17th, 2026, at 5:00 PM EDTPrecipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting.Precipio to Present at the Planet MicroCap Las Vegas
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Local Time, 12:00pm EST) at the Bellagio Resort & Hotel. Ilan Danieli, CEO and Zaki Sabet, COO of Precipio will be hosting the presentation and answering questions at the conclusion.Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio, Inc. (PRPO) Q1 2026 Earnings Call May 18, 2026 5:00 PM EDTCompany ParticipantsIlan Danieli - Founder, President, CEO & DirectorConference Call...
Read more news
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precipio
Sign Up For FreeTo access detailed company insights
Precipio, Inc., founded in 2011 and based in New Haven, Connecticut, is a specialized diagnostics company focused on reducing cancer misdiagnosis. The company partners with leading academic institutions in cancer research, diagnostics, and treatment to provide high-quality pathology services and diagnostic insights. Through its platform, Precipio d... Read More
